Type 2 Diabetes, Bariatric Surgery, Fasting, and GLP-1s: What We Finally Learned About a Disease We Thought We Understood

For years, I watched something happen in bariatric surgery that made very little sense, according to the medical textbooks of the time.

Patients with type 2 diabetes would undergo surgery, and within days, their blood sugars would improve dramatically. Some would leave needing far less insulin. Others would stop insulin entirely. Many of them would eventually remain off diabetes medications for years.

Now here is the important part:

They had not yet lost significant weight.

That observation mattered enormously.

Because if diabetes improvement were simply the result of fat disappearing from the body over time, then blood sugar should improve slowly over months as weight comes off.

But that was not what we saw.

Instead, patients barely eating — sipping broth and protein shakes while recovering from surgery — were suddenly metabolically different almost immediately.

At the time, we knew it worked. What we did not fully understand was why.

And honestly, that story tells you something important about medicine and science: sometimes clinical medicine notices the truth before biology fully explains it.

For decades, type 2 diabetes was often taught in very mechanical terms. You gained weight. You became insulin-resistant. The pancreas worked harder and harder until it “burned out.” Then you needed insulin.

That explanation was not entirely wrong. However, it was incomplete. Furthermore, it encouraged a kind of fatalism around type 2 diabetes, as though progression were inevitable and irreversible for everyone.

Then, bariatric surgery complicated the narrative.

Meanwhile, researchers like Professor Roy Taylor at Newcastle University began developing a much more dynamic understanding of what was actually happening inside the liver and pancreas.

And suddenly, many of the strange things bariatric surgeons had observed for years started making sense.

The Problem May Not Be Sugar Alone

One of the most common mistakes in nutrition discourse is assuming that blood sugar itself is the disease.

It is not.

Blood sugar is often the visible signal of a much larger metabolic problem involving:

• the liver,
• the pancreas,
• adipose tissue,
• appetite signaling,
• inflammation,
• gut hormones,
• and the brain itself.

Now, to be fair, refined carbohydrates and ultra-processed foods absolutely can worsen insulin resistance and glucose control. Sugary beverages, highly refined starches, and hyperpalatable processed foods create enormous metabolic stress for many people.

However, reducing the entire disease of type 2 diabetes to “sugar is poison” oversimplifies what is actually a highly complex biological system.

If carbohydrates alone caused diabetes, then traditional Mediterranean populations consuming beans, lentils, intact grains, and fruit would have universally developed severe metabolic disease. Yet many of those populations historically had some of the best cardiovascular and metabolic outcomes in the world.

Similarly, bariatric surgery would not improve diabetes before substantial fat loss occurred.

Something deeper was happening.

Roy Taylor and the Twin Cycle Hypothesis

Roy Taylor’s Twin Cycle Hypothesis is one of the most elegant modern explanations for type 2 diabetes.

The theory proposes that type 2 diabetes develops through two interconnected metabolic cycles, involving excess fat accumulation in organs not designed to store large amounts of fat.

First comes the liver. When caloric intake chronically exceeds what the body can safely store in adipose tissue, fat begins accumulating in the liver. Eventually, the liver becomes insulin-resistant. Now the liver starts misbehaving metabolically. Instead of calming down glucose production when insulin is present, the liver continues to release glucose into the bloodstream. At the same time, it exports excess triglycerides and fat particles into circulation.

• This creates a vicious cycle:
• more liver fat,
• more insulin resistance,
• higher insulin levels,
• more glucose production.

Then comes the second cycle. Those excess fat particles eventually accumulate in the pancreas itself. And that is where the beta cells begin struggling.

The Beta Cell Is Not Simply “Burned Out”

For years, we talked about the pancreas as though it simply became exhausted.

However, newer biology suggests something more complicated — and more hopeful.

Beta cells produce insulin, which is a protein. Proteins must be folded properly inside the cell before they can be packaged and secreted.

Under chronic metabolic stress — high glucose levels, elevated fatty acids, inflammation, oxidative stress — the protein-folding machinery inside the beta cell begins malfunctioning.

Some insulin molecules become misfolded.

Now imagine a factory assembly line where defective products begin to accumulate faster than workers can remove them.

The system clogs. The beta cell experiences what is called endoplasmic reticulum stress, or ER stress. In simple terms, the protein-processing machinery becomes overloaded.

At first, the cell adapts. It slows production. And the cell will activate repair systems. To clear damaged proteins.

But if the stress continues long enough, the machinery begins failing. Some beta cells become dysfunctional. As a result, some become metabolically suppressed. They stop making insulin. Some dedifferentiate, meaning they stop functioning normally. And eventually some undergo apoptosis: programmed cell death.

That distinction matters enormously. Because it suggests that not every beta cell is permanently destroyed early in the disease. Some are simply overwhelmed.

Why Fasting Sometimes Works

This may help explain why fasting improves type 2 diabetes in some patients.

Fasting reduces metabolic demand.

• Less glucose enters the system.
• Less insulin is required.
• The liver produces less glucose.
• The pancreas experiences less pressure.

In effect, fasting may temporarily reduce the metabolic traffic jam overwhelming the beta cells.

Now, some people online treat fasting almost like a mystical cure for diabetes. I think that is an exaggeration.

The body is not achieving enlightenment because somebody skipped breakfast.

The likely benefit is much more practical:

Reduced metabolic overload allows stressed systems to recover function.

And clinically, we do see this. Some patients improve dramatically with fasting or aggressive caloric restriction. However, fasting is not universally successful because not all patients have the same remaining beta-cell reserve. Some patients have substantial recoverable function left. Others have experienced years of apoptosis and structural loss.

That is one reason newly diagnosed patients often respond far better than patients with decades of poorly controlled diabetes.

Duration matters. Furthermore, what happens after the fasting matters enormously.

If someone fasts aggressively, but then returns immediately to hyper-palatable ultra-processed food, liquid calories, and chronic overnutrition, the same metabolic stress returns.

Which brings us to an important point.

The Real Goal Is Not Carb Elimination

This is where I part ways somewhat with the more absolutist low-carb community.

Low-carb diets help many patients reduce caloric intake and improve glucose control. That part is real.

However, when you look at the broader evidence, the deeper lesson is probably not:

“Carbohydrates are evil.”

The deeper lesson is: eat less, eat better, and create a sustainable metabolic environment that the body can actually manage long term.

And this is where Mediterranean-style dietary patterns continue to shine.

Why the Mediterranean Diet Works So Well

One of the strangest developments in modern nutrition culture is the fear surrounding whole grains and legumes.

Beans somehow became suspicious.

Oatmeal became controversial.

Meanwhile, the modern industrial food environment quietly engineered ultra-processed calorie delivery systems powerful enough to overwhelm normal satiety pathways entirely.

Perspective matters.

After bariatric surgery, once patients had healed from the immediate postoperative phase, many naturally transitioned toward what was essentially a Mediterranean-style eating pattern.

Not because it was trendy.

Because clinically it worked. But because patients tolerated it well. Their weight stabilized more successfully. In addition, cardiovascular risk factors improved. And perhaps most importantly, they could sustain it.

That last point matters more than anything else in nutrition.

The Mediterranean diet works because it aligns well with human physiology:

• high fiber,
• intact foods,
• lower caloric density,
• reduced ultra-processed food burden,
• improved satiety,
• favorable effects on the microbiome,
• and long-term sustainability.

Importantly, carbohydrates behave differently from rapidly absorbed refined starches and sugary beverages.

• Food structure matters
• Fiber matters.
• Satiety matters.
• Context matters.

A bowl of lentils with olive oil, vegetables, and fish is metabolically different from ultra-processed food engineered to bypass normal fullness signaling.

Whole grains are not the apocalypse.

GLP-1 Drugs and Bariatric Surgery Are Teaching the Same Lesson

GLP-1 medications work so well because they address biology directly.

They:

• reduce appetite,
• slow gastric emptying,
• improve satiety,
• decrease caloric intake,
• lower liver fat,
• and reduce metabolic demand.

In many ways, these medications reproduce medically some of the metabolic effects bariatric surgeons observed years ago.

Importantly, they help patients sustain the physiologic state required for remission.

And this is where the conversation about obesity often becomes deeply unfair.

For decades, medicine and society moralized obesity, while underestimating how aggressive biology defends body weight.

Hunger increases with weight loss.

Energy expenditure decreases.

Food reward intensifies.

The environment constantly pushes hyperpalatable calories. This is not weakness. It is biology.

Remission Is Still a Victory

One of the more frustrating debates online revolves around the word “cure.”

I understand why people want to use it. Remission sounds less dramatic. Less triumphant.

However, remission is actually an extraordinarily hopeful concept. It means the disease process can improve substantially. But also, it means biology is more dynamic than we once believed. Finally, it means the pancreas retains recoverable function in many patients.

But remission also recognizes reality:

• Some beta cells are permanently lost,
• Relapse can occur,
• weight regain matters,
• disease duration matters,
• and long-term susceptibility often remains.

That is not pessimism. That is biological honesty.

The real breakthrough here is not that type 2 diabetes was fake all along. The breakthrough is that we finally understand it as a far more dynamic, reversible, and biologically complex disease than we once believed. And perhaps the most important lesson of all is this:

Bariatric surgery, fasting research, Mediterranean diets, and GLP-1 science are not actually telling completely different stories. They are all pointing toward the same underlying truth:

The human body functions well when chronic metabolic overload is reduced long enough for normal signaling systems to recover.

The tragedy of type 2 diabetes is not merely that millions have developed it. But that for decades, we blamed patients morally, while barely understanding the biology ourselves.

Then, patients stopped eating after surgery, and their diabetes improved before the sutures had healed.

Biology was trying to teach us something.

Eventually, science listened.